<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of results obtained in in vitro bone marrow cell culture as per ml of aspirated marrow instead of per 10(5) nucleated cells plated as studied in 41 patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and 79 patients with a <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">dysmyelopoietic syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Four types of growth were found in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients: three with hypercellular marrow and either (a) microclusters, (b) isolated cells, or (c) macroclusters and a complete remission (CR) rate of 86%, 63%, and 14% respectively; (d) relative <z:e sem="disease" ids="C0151773" disease_type="Disease or Syndrome" abbrv="">hypocellular marrow</z:e> with a CR rate of 0% </plain></SENT>
<SENT sid="2" pm="."><plain>This type of poorly responsive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patient has recently been described [17] </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">dysmyelopoietic syndromes</z:e> were subdivided into three groups according to th type of in vitro growth: subnormal, decreased, and leukemic </plain></SENT>
<SENT sid="4" pm="."><plain>There was a good correlation between these in vitro groups and the outcome of patients: long survival, <z:hpo ids='HP_0011420'>death</z:hpo> from hemorrhagic and/or infectious complications, leukemic transformation (logrank test: chi 2 = 9.12, df = 2, p = 0.01) </plain></SENT>
</text></document>